Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine plus propofol dose-finding for bidirectional endoscopy in adults with subclinical obesity
ChiCTR2400095070Phase 4Recruiting
- Sponsor
- The Fifth People's Hospital of Huai'an
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oliceridine and propofol in obesity (2 arms), sponsored by The Fifth People's Hospital of Huai'an. Primary endpoint: Gastroscope placement reaction. Started Jan 2025; status: recruiting.
02
Drugs
oliceridinepropofol
03
Conditions
obesity
Beyond the preview
Go deeper on ChiCTR2400095070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400095070.